Abstract:Importance: The United States spends more on health care than any other country, with costs approaching 18% of the gross domestic product (GDP). Prior studies estimated that approximately 30% of health care spending may be considered waste. Despite efforts to reduce overtreatment, improve care, and address overpayment, it is likely that substantial waste in US health care spending remains. Objectives: To estimate current levels of waste in the US health care system in 6 previously developed domains and to report estimates of potential savings for each domain. Evidence: A search of peer-reviewed and "gray" literature from January 2012 to May 2019 focused on the 6 waste domains previously identified by the Institute of Medicine and Berwick and Hackbarth: failure of care delivery, failure of care coordination, overtreatment or low-value care, pricing failure, fraud and abuse, and administrative complexity. For each domain, available estimates of waste-related costs and data from interventions shown to reduce waste-related costs were recorded, converted to annual estimates in 2019 dollars for national populations when necessary, and combined into ranges or summed as appropriate. Findings: The review yielded 71 estimates from 54 unique peer-reviewed publications, government-based reports, and reports from the gray literature. Computations yielded the following estimated ranges of total annual cost of waste: failure of care delivery, $102.4 billion to $165.7 billion; failure of care coordination, $27.2 billion to $78.2 billion; overtreatment or low-value care, $75.7 billion to $101.2 billion; pricing failure, $230.7 billion to $240.5 billion; fraud and abuse, $58.5 billion to $83.9 billion; and administrative complexity, $265.6 billion. The estimated annual savings from measures to eliminate waste were as follows: failure of care delivery, $44.4 billion to $97.3 billion; failure of care coordination, $29.6 billion to $38.2 billion; overtreatment or low-value care, $12.8 billion to $28.6 billion; pricing failure, $81.4 billion to $91.2 billion; and fraud and abuse, $22.8 billion to $30.8 billion. No studies were identified that focused on interventions targeting administrative complexity. The estimated total annual costs of waste were $760 billion to $935 billion and savings from interventions that address waste were $191 billion to $286 billion. Conclusions and relevance: In this review based on 6 previously identified domains of health care waste, the estimated cost of waste in the US health care system ranged from $760 billion to $935 billion, accounting for approximately 25% of total health care spending, and the projected potential savings from interventions that reduce waste, excluding savings from administrative complexity, ranged from $191 billion to $286 billion, representing a potential 25% reduction in the total cost of waste. Implementation of effective measures to eliminate waste represents an opportunity reduce the continued increases in US health care expenditures.

Implementing Healthcare Excellence: The Vital Role of the CEO in Evidence-Based Design

Analyzing how data analytics is used in detecting and preventing fraudulent health insurance claims

Unexpected Flow Cytometric Results with two Small GPIIb/IIIa Blockers: Eptifibatide and Tirofiban

MedicareVis: a Joint Visual Analytics Approach for Anti-Fraud in Medical Insurance

Unraveling Medicare and Medicaid Prescription Drug Fraud and Abuse

A Study of Health Insurance Fraud in China and Recommendations for Fraud Detection and Prevention

Fourteen years of manifestations and factors of health insurance fraud, 2006-2020: a scoping review

Estrogen receptors, progestin receptors and DNA synthesis in the macaque endometrium during the luteal-follicular transition

Research on the risk governance of fraudulent reimbursement of patient consultation fees

Impact of Business Operations and Policies on Healthcare Costs

Summarizing a posterior distribution of trees using agreement subtrees.

Waste in the US Health Care System: Estimated Costs and Potential for Savings

Approaches for identifying U.S. medicare fraud in provider claims data

Sharing and Analyzing Data to Reduce Insurance Fraud

[A clinical case of ABO-incompatible living renal transplantation].

Fraud Analytics: A Decade of Research -- Organizing Challenges and Solutions in the Field

Cyber threats to health information systems: A systematic review

Hospital cost structure in the USA: what's behind the costs? A business case

Healthcare insurance fraud detection using data mining

The inefficient effects of non-clinical factors on health care costs

Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system